DISSECTIONING RISK FACTORS FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML) AFTER AUTOTRANSPLANTS FOR PLASMA CELL MYELOMA AND LYMPHOMAS

被引:0
|
作者
Hashmi, S. [1 ]
Dean, R. M. [2 ]
Shaw, B. [3 ]
Brazauskas, R. [3 ]
Millard, H. [3 ]
Battiwalla, M. [4 ]
Savani, B. [5 ]
Flowers, M. E. [6 ]
Cooke, K. R. [7 ]
Hamilton, B. K. [2 ]
Kalaycio, M. [8 ]
Radivoyevitch, T. [9 ]
Litzow, M. R. [10 ,11 ]
Gale, R. P. [12 ]
机构
[1] Mayo Clin, Bone Marrow Transplant Program, Rochester, MN USA
[2] Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH USA
[3] MCW, CIBMTR, Milwaukee, WI USA
[4] NHLBI, Hematol Branch, Bethesda, MD 20892 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[7] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Pediat Blood & Marrow Transplantat Program, Baltimore, MD USA
[8] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[9] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[10] Mayo Clin, Div Hematol, Rochester, MN USA
[11] Mayo Clin, Transplant Ctr, Rochester, MN USA
[12] Imperial Coll London, Dept Med, Sect Hematol, London, England
关键词
D O I
10.1016/S0145-2126(17)30174-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
61
引用
收藏
页码:S41 / S41
页数:1
相关论文
共 50 条
  • [41] Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) Associated with PARP Inhibitors: A Real-World Analysis
    Gajra, Ajeet
    Zettler, Marjorie E.
    Klink, Andrew J.
    Feinberg, Bruce
    BLOOD, 2020, 136
  • [42] Del 5q as a sole cytogenetic abnormality in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Washington, LT
    Glassman, A
    Ibrahim, S
    Lai, R
    MODERN PATHOLOGY, 2001, 14 (01) : 182A - 182A
  • [43] Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents
    Navada, S. C.
    Odchimar-Reissig, R.
    Reddy, E. P.
    Demakos, E. P.
    Holland, J. F.
    Wilhelm, F.
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2013, 37 : S146 - S146
  • [44] Contemporary understanding of myeloid-derived suppressor cells in the acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) tumor microenvironment
    Alhajahjeh, Abdulrahman
    Stahl, Maximilian
    Kim, Tae K.
    Kewan, Tariq
    Stempel, Jessica M.
    Zeidan, Amer M.
    Bewersdorf, Jan Philipp
    EXPERT REVIEW OF ANTICANCER THERAPY, 2025,
  • [45] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [46] Longitudinal analysis of angiogenic factors and vascularity in acute myeloid leukemia (AML) and mylodysplastic syndrome (MDS).
    Aguayo, A
    Estey, E
    Kantarjian, H
    Manshouri, T
    Rogers, A
    Giles, FJ
    Albitar, M
    BLOOD, 2000, 96 (11) : 320A - 320A
  • [47] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
  • [49] Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation
    Heuser, Michael
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Kreimeyer, Henriette
    Pankratz, Mira
    Flintrop, Madita
    Liebich, Alessandro
    Klesse, Sabrina
    Panagiota, Victoria
    Stadler, Michael
    Wichmann, Martin
    Shahswar, Rabia
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kreipe, Hans-Heinrich
    Germing, Ulrich
    Ganser, Arnold
    Kroeger, Nicolaus
    Koenecke, Christian
    Thol, Felicitas
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1361 - 1372
  • [50] TRISOMY-14 IN ACUTE MYELOGENOUS LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    TOZE, CL
    BARNETT, MJ
    NAIMAN, SC
    HORSMAN, DE
    BLOOD, 1994, 84 (10) : A626 - A626